CLOROX CO /DE/ Earnings Per Share Disclosure
| 2025 | 2024 | 2023 | |||||||||||||||
| Basic | 123,525 | 124,174 | 123,589 | ||||||||||||||
| Dilutive effect of stock options and other | 762 | 630 | 592 | ||||||||||||||
| Diluted | 124,287 | 124,804 | 124,181 | ||||||||||||||
| Antidilutive stock options and other | 3,085 | 2,704 | 1,444 | ||||||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Aug 8, 2025 | Showing above |
| 2024 | Aug 8, 2024 | |
| 2023 | Aug 10, 2023 | |
| 2022 | Aug 10, 2022 | |
| 2021 | Aug 10, 2021 | |
| 2020 | Aug 13, 2020 | |
| 2019 | Aug 14, 2019 | |
| 2018 | Aug 14, 2018 | |
| 2017 | Aug 15, 2017 | |
| 2016 | Aug 16, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.